mRNA-based anti-COVID-19 vaccines induced higher B cells and IgG levels than whole virus-based: A pilot study on Egyptian individuals
Human Antibodies · 13.11.2026
DOI: 10.1177/10932607261506645 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Antibodies, online erschienen am 13.11.2026. Verfasst von Sohaila M Khalil und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center of Excellence in Cancer Research, Tanta University Teaching Hospital, Tanta University, Tanta, Egypt. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Academy of Scientific Research and Technology.
Abstract (Originalsprache)
Background
B cells are critical components of vaccine-induced humoral immunity. However, circulating total B-cell measurements do not by themselves establish antigen specificity, memory differentiation, neutralizing activity, or protection.
Aim
This exploratory observational study compared circulating CD19+ B-cell numbers and anti-SARS-CoV-2 spike receptor-binding domain (RBD) binding antibody levels according to COVID-19 vaccine platform and time since vaccination.
Methods
Sixty-one participants were included: 52 vaccinated participants and 9 non-vaccinated participants. Vaccinated participants had received Pfizer (BNT162b2), ChAdOx1 nCoV-19, or inactivated-virus vaccines (Sinopharm or Sinovac). Peripheral blood mononuclear cells were analyzed by flow cytometry using CD19 to quantify total circulating B cells, while anti-SARS-CoV-2 spike-RBD binding antibodies were measured using the Elecsys Anti-SARS-CoV-2 S assay.
Results
Total CD19+ B-cell percentages and absolute numbers were not significantly different between the vaccinated platform groups and the non-vaccinated controls. Anti-SARS-CoV-2 spike-RBD binding antibody levels were significantly higher in vaccinated participants than in controls. The relationship between circulating CD19+ B-cell frequency and antibody concentration was weak.
Conclusion
These exploratory findings suggest persistent humoral immune responses after COVID-19 vaccination but do not establish superiority of one vaccine platform. Because the study was limited by sample size, heterogeneous. vaccination histories, incomplete objective ascertainment of previous SARS-CoV-2 infection, and use of a binding-antibody assay rather than a functional neutralization assay, the findings should be interpreted as preliminary and require confirmation in larger, adequately powered studies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center of Excellence in Cancer Research, Tanta University Teaching Hospital, Tanta University, Tanta, Egypt.
- Zoology Department, Faculty of Science, Tanta University, Tanta, Egypt.
- Zoology Department, Faculty of Science, Damanhur University, Damanhur, Egypt.
- Zoology Department, Faculty of Science, Damietta University, Tanta, Egypt.
ORCID-Profile: Walaa G Ahmed, Elـhassan M Mokhamer
Förderung
- Academy of Scientific Research and Technology
Zitieren
APA
Khalil, S. M., Ahmed, W. G., El-Bakry, K. A., Mokhamer, E. M., Sanoh, N. E., & Salem, M. L. (2026). mRNA-based anti-COVID-19 vaccines induced higher B cells and IgG levels than whole virus-based: A pilot study on Egyptian individuals. Human Antibodies. https://doi.org/10.1177/10932607261506645
Vancouver
Khalil SM, Ahmed WG, El-Bakry KA, Mokhamer EM, Sanoh NE, Salem ML. mRNA-based anti-COVID-19 vaccines induced higher B cells and IgG levels than whole virus-based: A pilot study on Egyptian individuals. Human Antibodies. 2026. doi:10.1177/10932607261506645
BibTeX
@article{Khalil2026,
author = {Khalil, Sohaila M and Ahmed, Walaa G and El-Bakry, Kadry A and Mokhamer, Elـhassan M and Sanoh, Noura E and Salem, Mohamed L},
title = {mRNA-based anti-COVID-19 vaccines induced higher B cells and IgG levels than whole virus-based: A pilot study on Egyptian individuals},
journal = {Human Antibodies},
year = {2026},
doi = {10.1177/10932607261506645}
}
EUVIMED